China 4-(4-Ethylpiperazin-1-ly)aniline Factory

Each individual member from our significant effectiveness gross sales workforce values customers' demands and small business communication for 4-(4-Ethylpiperazin-1-ly)aniline,CAS NO 115619-01-7,115619-01-7,Infigratinib intermediate,Infigratinib advance intermediate, We hope we can have a friendly relationship with businessman from all over the world.
4-(4-Ethylpiperazin-1-ly)aniline, With the effort to keep pace with world's trend, we are going to always endeavor to meet customers' demands. If you want develop any other new products and solutions, we can customize them in your case. If you feel interest in any of our goods or want develop new merchandise, remember to feel free to contact us. We're looking forward to forming successful business relationship with customers all over the world.

Hot Products

  • L-Norvaline

    L-Norvaline

    Product Name:L-Norvaline
    Molecular Formula:C5H11NO2
    Molecular Weight:117.15
    CAS Registry Number:6600-40-4
  • 3-Tolylboronic acid

    3-Tolylboronic acid

    Product Name:3-Tolylboronic acid
    Molecular Formula:C7H9BO2
    Molecular Weight:135.96
    CAS Registry Number:17933-03-8
  • Netilmicin sulfate

    Netilmicin sulfate

    Product Name:Netilmicin sulfate
    Molecular Formula:C42H92N10O34S5
    Molecular Weight;1441.55
    CAS Registry Number;56391-57-2
  • Diclofenac sodium Injection

    Diclofenac sodium Injection

    Product Name:Diclofenac sodium Injection
    Dosage:75mg/3m1-50ampoule
    Application:Antiphlogistic
  • 1-Bromo-2,5-difluorobenzene

    1-Bromo-2,5-difluorobenzene

    Product Name:1-Bromo-2,5-difluorobenzene
    Molecular Formula:C6H3BrF2
    Molecular Weight:192.99
    CAS Registry Number:399-94-0
  • Dipyridamole

    Dipyridamole

    Product Name:Dipyridamole
    Molecular Formula:C24H40N8O4
    Molecular Weight;504.63
    CAS Registry Number;58-32-2

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept